Clinical Trials Logo
  1. Home
  2. Severe Depression
  3. NCT03380442

Psilocybin and Depression — Psilo101  

Severe Depression Clinical Trial

Official title:
Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression

Clinical Trial Summary

The main aim of the study is to investigate the possible long-term therapeutic effects of psilocybin on the symptoms of severe depression, as well as the brain mechanisms underlying these changes. Depression severity is assessed before and after (i.e., 1 week, 3 months and 6 months after) a single dose of psilocybin and compared to respective scores of a group receiving an active placebo, ketamine. Brain activity (using functional magnetic resonance imaging) is measured before and one week after drug administration in order to determine whether changes in brain networks related to emotional and self-referential processing correlate with any observed changes in depression scores. Further, blood samples will be obtained from the participants and analyzed in order to reveal gene expression and molecular level correlates underlying rapid antidepressant effects, and to identify biomarkers that predict treatment outcome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03380442
Study type Interventional
Source Helsinki University
Contact Mona E Moisala, PhD
Phone 504480044
Email mona.moisala@helsinki.fi
Status Not yet recruiting
Phase Phase 2
Start date September 2018
Completion date September 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Completed NCT02957591 - Probiotic Supplementation in Severe Depression N/A
Recruiting NCT05842278 - The Dosage Effect of pBFS Guided rTMS Treatment for MDD N/A
Not yet recruiting NCT05957341 - pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD N/A
Recruiting NCT05964036 - pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive Disorder N/A
Recruiting NCT03862209 - Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia N/A
Active, not recruiting NCT03892473 - Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E ) N/A
Active, not recruiting NCT03837340 - Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health N/A
Enrolling by invitation NCT03922425 - Community-based Mental Health Care for People With Severe and Enduring Mental III Health N/A
Recruiting NCT06112652 - Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique N/A
Completed NCT02522377 - Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression N/A
Completed NCT02715986 - Brain Changes in Severely Depressed Patients Before and After Treatment With Electroconvulsive Therapy N/A